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Abstract
The extensive use of avidin and streptavidin in life sciences originates from the extraordinary tight biotin-binding affinity of
these tetrameric proteins. Numerous studies have been performed to modify the biotin-binding affinity of (strept)avidin to
improve the existing applications. Even so, (strept)avidin greatly favours its natural ligand, biotin. Here we engineered the
biotin-binding pocket of avidin with a single point mutation S16C and thus introduced a chemically active thiol group,
which could be covalently coupled with thiol-reactive molecules. This approach was applied to the previously reported
bivalent dual chain avidin by modifying one binding site while preserving the other one intact. Maleimide was then coupled
to the modified binding site resulting in a decrease in biotin affinity. Furthermore, we showed that this thiol could be
covalently coupled to other maleimide derivatives, for instance fluorescent labels, allowing intratetrameric FRET. The
bifunctional avidins described here provide improved and novel tools for applications such as the biofunctionalization of
surfaces.
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Introduction
The extremely high affinity of avidin and streptavidin towards
D-biotin (Kd<6610
216 M for avidin and Kd<4610
214 M for
streptavidin) [1–3] is the reason why these proteins are widely
applied in life sciences. Biotin occupies a structurally optimal
cavity inside the eight-stranded beta barrel of (strept)avidin
forming several hydrogen bonds with the protein [4–6]. Previous
studies have indicated the importance of a particular set of residues
in this interaction. However, removal of a single hydrogen-
bonding residue weakened biotin binding to (strept)avidin only
moderately [7–11]. Therefore, fairly radical mutations have to be
applied in order to extinguish the biotin-binding activity of
(strept)avidin as previously reviewed [2]. In another approach,
biotin was chemically adjusted to increase its binding affinity, but
with poor results [12]. Two studies reported rational engineering
of streptavidin, where the ligand-binding specificity of mutant
streptavidin was altered from biotin to its analog, 2-iminobiotin
[13], or to biotin-4-fluorescein [14]. Avidin was also modified to
improve the binding of 49-hydroxyazobenzene-2-carboxylic acid
(HABA) resulting in a change of several orders of magnitude in the
binding affinity as compared to wild type (wt) avidin [15].
However, avidin could not be converted to favour binding of
HABA over biotin. Overall, the site-directed modulation of the
ligand-binding specificity of (strept)avidins towards ligands other
than biotin or its derivatives appears to be challenging.
The independent control of individual binding sites within
tetrameric (strept)avidin has been the motivation for numerous
studies. A monovalent streptavidin tetramer with only one
functional biotin binding site was reported [16]: The unmodified
and modified monomers were combined in a denaturated state at
a molar ratio of 1:3 before refolding. This method created a
mixture of tetramers of different compositions from monovalency
to tetravalency following isolation of the monovalent protein from
the oligovalent forms. This laborious procedure could be avoided
by genetically joining two or four modified subunits together into a
polypeptide chain like in the dual chain and single chain avidins
previously reported [17,18]. The same approach has since also
been applied to streptavidin [14].
Dual chain avidin (dcAvd) is a subunit fusion of two different
circularly permuted avidin monomers, circularly permuted avidin
5R4 (cpAvd5R4) and circularly permuted avidin 6R5
(cpAvd6R5) [17]. Two dcAvd subunits, both with two binding
sites, form a dimer with four binding sites (Figure 1A). The
subunits can independently be modified, making it possible to
create avidins with altered binding sites, for instance for low-
affinity and high-affinity binding of a ligand within a single protein
molecule [7]. The use of a disulphide bridge (I117C5R4,
numbering according to wt avidin) combined with a critical
mutation (V115H6R5) in the interface between subunits [19] made
it possible to develop dcAvds with defined quaternary structures
[20]. DcAvd provides a scaffold that can be modified not only to
alternate affinity for a ligand, but also to change specificity – in
other words to favour another ligand molecule instead of biotin.
In order to overcome the challenge of modifying the extremely
high biotin-binding affinity of (strept)avidin, we established a novel
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e16576concept, in which a cysteine residue was introduced into the ligand
binding site of avidin. The thiol group of the cysteine could then
be covalently modified leading to the inhibition of biotin-binding.
In addition, this allowed the selective covalent linking of thiol
group reactive molecules to avidin. Furthermore, an avidin with
two specific ligand-binding sites was created by applying the same
modification to dcAvd.
Results
Serine 16 replaced by cysteine can be modified by
maleimide
Serine 16 is positioned in the biotin-binding pocket of avidin and
is hydrogen bonded to a ureido oxygen in biotin in the avidin-biotin
complex (PDB 2AVI; Figure 1B,D). Our strategy was to replace
serine 16 with a cysteine to introduce a thiol group to the
polypeptide available for covalent bonding with small thiol-reactive
molecules. Importantly, being located inside the binding pocket, the
free thiol group is unable to form disulphide bond between another
avidin subunit, which would lead to oligomeric assemblies [21], and
therefore reducing conditions were not needed for protein handling.
Cysteine 16 could then be modified by maleimide, which reacts
specifically with thiol group in chemically mild conditions forming a
stable thioether linkage (Figure 1C). Furthermore, Cys16 could be
covalently coupled to other maleimide derivatives, as demonstrated
here by linking a maleimide-activated fluorescent probe to
dcAvd(I117C5R4S16C,V115H6R5), referred to as dcAvd-Cys from
now on. DcAvd-Cys could be coupled to two different kinds of
molecules, to thiol-reactive molecules as well as to biotinylated
molecules.
We produced avidin and Avd(S16C) in E. coli cells and dcAvd-
Cys in baculovirus infected Sf9 insect cells. This was followed by
successful protein purification by one-step 2-iminobiotin affinity
chromatography [22] indicating protein solubility and activity in
the form of biotin binding. The purified proteins were of the
correct size according to SDS-PAGE analysis (Figure 1E). Non-
reducing SDS-PAGE showed the formation of a thioether between
the dcAvd-Cys subunits (Figure 1E).
We used high-resolution electrospray ionization Fourier trans-
form ion cyclotron resonance (ESI FT-ICR) mass spectrometry to
confirm protein primary structures and to detect the efficiency of
coupling maleimide into Avd(S16C). Figure 2 shows isotopically-
resolved, charge-deconvoluted ESI FT-ICR mass spectra for wt
avidin, Avd(S16C) and Avd(S16C) coupled with maleimide (MI).
Based on the mass data, both wt avidin and Avd(S16C) had three
additional amino acid residues (QTV) of the B. avium OmpA signal
peptide in the N-terminus of the protein and contained an
intramolecular disulfide bridge, Cys4–Cys83 (the theoretical
masses are 14668.43 and 14684.41 Da for wt avidin and
Avd(S16C), respectively). In addition, both proteins appeared in
two different forms, separated by 17 Da, due to the partial
cyclization of an N-terminal glutamine residue into the pyrroli-
Figure 1. Avidin-ligand interaction. (A) Avidin tetramer (PDB 2AVI), with subunits numbered according to [5]. Subunits are coloured to red and
blue according to dual chain avidin subunits; cpAvd5R4 are shown in red and cpAvd6R5 are shown in blue. (B) A cartoon model of wild type (wt)
avidin (PDB 2AVI) showing the biotin-binding contact residues in sticks. Oxygen atoms are shown in red, nitrogens in blue, sulphurs in yellow, and
carbon atoms in grey. The W110 residue from the neighboring subunit is highlighted in cyan. (C) The cartoon model of the maleimide-treated
binding site of Avd(S16C) showing a thioether bond between Cys16 and maleimide. (D) A schematic of the hydrogen bonds between wt avidin and
biotin. Bond lengths in a ˚ngstro ¨ms are shown according to (PDB 2avi) [6]. (E) SDS-PAGE analysis of recombinant proteins shows high purity and
correct molecular weights. In the presence (+) of the reducing agent b-mercaptoethanol (b-ME), Avidin, Avd(S16C) and dcAvd-Cys (more specifically
dcAvd(I117C5R4S16C,V115H6R5)) exist as monomers of sizes ,14.5 kDa, ,14.5 kDa and ,30 kDa, respectively. DcAvd-Cys without (-) the reducing
agent exists mainly in the form of a disulfide linked dimer, ,60 kDa. M, molecular weight marker.
doi:10.1371/journal.pone.0016576.g001
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or higher oligomers were detected, indicating the absence of C16-
mediated tetramer crosslinking. We incubated a high molar excess
of maleimide with Avd(S16C) to measure coupling efficiency with
the free cysteine present in the protein structure. A mass spectrum
of Avd(S16C) treated with maleimide (Figure 2C) consistently
showed a mass increase of +97 Da, indicating the formation of a
covalent thioether linkage, presumably with Cys16 (theoretical
mass 14781.43 Da). The coupling efficiency appeared to be high
since only a small amount of unreacted protein was present in the
sample. We detected no other protein modifications upon the
maleimide treatment. We obtained similar results when
Avd(S16C) was treated with N-ethylmaleimide, another thiol-
reactive maleimide derivative, showing nearly 100% coupling
efficiency (data not presented). In contrast, treatment of wt avidin
with maleimide or N-ethylmaleimide showed no reaction at all, as
expected, indicating high specificity of the two reagents towards
free thiol groups in these conditions.
To further verify the presence of the maleimide-coupled residue,
wt avidin as well as Avd(S16C), with or without maleimide
treatment, were digested in solution with trypsin (data presented as
Table S1 in Supporting Information). The full sequence coverage
was obtained, except in the case of Avd(S16C) (87%), represented
by up to 20 specific tryptic peptides. Among the identified peptides
for Avd(S16C) treated with maleimide, a peptide having a
monoisotopic mass of 1947.8630 Da was observed, consistent
with the maleimide conjugation into residues 10–26 (theoretical
mass 1947.8567 Da). With untreated Avd(S16C), this peptide was
absent, but a peptide having a monoisotopic mass of
1850.8512 Da was observed instead, corresponding to the
uncoupled tryptic peptide 10–26. These results indicate that
maleimide was effectively and specifically conjugated to the Cys16
residue in the modified Avd(S16C). The digestion data also
confirmed the presence of intramolecular disulfide bridge (disulfide
linked tryptic peptides 3–9+72–94 and 4–9+72–94) as well as the
N-terminal PCA modification.
Figure 2. A charge-deconvoluted ESI FT-ICR mass spectra for avidin, Avd(S16C) and Avd(S16C) conjugated with maleimide. The
mass spectra showed that both avidin (A) and Avd(S16C) (B) have three additional N-terminal amino acid residues (QTV) of the B. avium OmpA signal
peptide and they both contain an intramolecular disulfide bridge (theoretical masses are 14668.43 and 14684.41 Da for avidin and Avd(S16C),
respectively). The proteins appeared in two different forms separated by 17 Da due to the partial cyclization of an N-terminal glutamine residue into
the pyrrolidone carboxylic acid (PCA) form. The mass spectrum of Avd(S16C) conjugated with maleimide (MI) (C) showed a mass increase of +97 Da,
indicating a formation of a covalent thioether linkage with Cys16 (theoretical mass 14781.43 Da). The small amount of unreacted protein present in
the sample indicated high coupling efficiency between maleimide and the cysteine-residue.
doi:10.1371/journal.pone.0016576.g002
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decreases affinity to biotin
The thermal stability of Avd(S16C) in the absence of biotin was
comparable to that of wt avidin (Table 1, see also Figure S1).
However, the S16C mutation had a negative effect on the thermal
stability of the quaternary structure of wt avidin in the presence of
biotin, since the thermal transition temperature decreased about
20uC. This was expected, as the mutation was targeted to one of
the key residues participating in ligand binding. Similarly to
dcAvd(I117C5R4,V115H6R5), dcAvd-Cys was a monomer at
room temperature (RT, 2361uC) in the absence of biotin. The
presence of biotin stabilized dcAvd-Cys, although it lost its
pseudotetrameric structure at 60uC, which is about 20uC lower
than the thermal transition temperature determined for dcAv-
d(I117C5R4,V115H6R5) [20].
As was stated above, Avd(S16C) efficiently bound to a 2-
iminobiotin affinity matrix, which qualitatively suggested relatively
high biotin-binding affinity. We analyzed the ligand binding
properties of the modified avidins with a fluorescent biotin
conjugate, BF560-biotin, by measuring the quenching of fluores-
cence after protein binding at RT. The quenching of fluorescence
(Figure 3B) of wt avidin, Avd(S16C) and dcAvd-Cys were fairly
equal, 66.561.3, 61.060.6 and 63.267.3% respectively, indicat-
ing that the S16C mutation had only a modest effect on the
binding of the fluorescent biotin. However, after addition of free
biotin, the recovery of fluorescence (Figure 3C) of Avd(S16C) was
Figure 3. Biotin dissociation asays. (A) A schematic presentation of the four binding sites in avidin, Avd(S16C) and dcAv-
d(I117C5R4S16C,V115H6R5) (dcAvd-Cys). Biotin could bind to both of the S16C-mutated and unmodified binding sites (scheme 1). The biotin
binding to Avd(S16C) and dcAvd-Cys could be inhibited with maleimide, which forms a covalent bond with a thiol group in the modified binding site
(scheme 2 a,b). (B) The level of quenching of fluorescence of BF560-biotin after it was bound to protein indicated different biotin-binding abilities for
different protein forms with or without chemical coupling to maleimide (MI) or to N-maleoyl-b-alanine (Mal-b-ala). The means for duplicate
measurements are shown 6 s.d. (C, D) The recovery of fluorescence of BF560-biotin after the addition of a 100-fold excess of free biotin indicates
dissociation of the BF560-biotin-protein complex. (E) Proteins were incubated with
3H-biotin and unbound
3H-biotin was filtered and measured with
a scintillation counter. Means of triplicate measurements are shown 6 s.d. (F, G) The release of
3H-biotin after addition of cold biotin measured at
different time points.
doi:10.1371/journal.pone.0016576.g003
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24 s
21) compared to wt avidin
(kdiss=2.4610
25 s
21), indicating an increase in the dissociation
rate and thus decreased affinity to the conjugated biotin. After one
hour the recovery of fluorescence was nearly 15% with avidin and
85% with Avd(S16C). When compared to that of the previously
analyzed Avd(S16A) with its dissociation rate constant of
3.6610
24 s
21 and fluorescence recovery of 74.5% after one hour
[7], we can conclude that the mutations S16A and S16C affect the
biotin-binding properties of avidin in a similar fashion. The
recovery of fluorescence for dcAvd-Cys was slightly over 50% after
one hour and the dissociation rate constant 1.3610
24 s
21, being
thus five-fold faster than for wt avidin but three-fold slower than
for Avd(S16C). Because the pseudotetrameric dcAvd-Cys has two
S16C-modified and two unmodified binding sites, the result
appears logical: dcAvd-Cys behaves like an independent combi-
nation of wt avidin and Avd(S16C).
We used
3H-biotin to confirm the results we obtained for ligand
binding with fluorescently labelled biotin. Incubation of
3H-biotin
with proteins at RT following filtering and scintillation counting of
3H-biotin indicated differences in biotin-binding abilities. The
results appeared logical, since wt avidin bound almost all of the
3H-
biotin and the amount of free
3H-biotin was 2.760.1% (Figure 3E).
The
3H-biotin-bindingabilityofAvd(S16C)wassomewhatreduced,
since the amount of free biotin was 14.661.6%. The amount of
unbound
3H-biotin in the case of dcAvd-Cys was 5.160.6%
indicating a slightly reduced ability to bind
3H-biotin as compared
to wt avidin. The release of the bound
3H-biotin was measured after
the addition a 1000-fold excess of cold biotin and the dissociation
from Avd(S16C) (kdiss=6.4610
24 s
21) approached 85% after
24 hours, and therefore, dissociation was increased nearly 18-fold
as compared to wt avidin, which had released only 7% of the bound
3H-biotin after 24 hours (kdiss=3.6610
25 s
21) (Figure 3F). At
24 hours after addition of cold biotin the dissociation of the bound
3H-biotin from dcAvd-Cys approached 25% and was nearly five-
fold faster (kdiss=1.7610
24 s
21) than from wt avidin.
According to both assays biotin dissociation was much faster
from Avd(S16C) as compared to wt avidin. However, for dcAvd-
Cys the results of the two assays differed slightly. A possible reason
for this could be the structural differences of the used ligands. The
fluorescent label itself is large compared to biotin and when
attached to biotin via a linker, the label could affect biotin-binding
properties. D-[8,9-
3H]-biotin with two tritiums, on the other hand,
is structurally almost identical with natural D-biotin.
Blocking the biotin binding of avidins by coupling with
maleimide
We coupled maleimide to the binding sites of the modified
avidins (Figure 3A) and tested whether this had an effect on the
biotin binding-affinity as determined by using fluorescently
labelled BF560-biotin. Maleimide had no effect on the binding
properties of wt avidin (Figure 3B). In contrast, maleimide coupled
to Avd(S16C) disrupted the binding of fluorescent biotin, which
was seen as a decrease in the quenching of fluorescence to
36.160.7%. The recovery of fluorescence after the addition of free
biotin was rapid and most of the complexes were dissociated
already after one minute from the beginning of the measurement
(Figure 3D), indicating significant decrease in the affinity for
biotin. Ser16 is located in the loop area of b-barrel of avidin and
therefore it is possible that the loop may partly distort so that
biotin may fit in the binding site, although maleimide is already
covalently coupled to modified Cys16. Therefore, we were
interested to know whether maleimide with an attached side
group would prevent the binding of biotin to the modified site
more efficiently. We selected N-maleoyl-b-alanine (Mal-b-ala), a
maleimide with an attached three-carbon chain, and coupled it to
Avd(S16C). However, the quenching of fluorescence did not
decrease, although the recovery of fluorescence after the addition
of free biotin was even faster in the case of Mal-b-ala than bare
maleimide (Figure 3D) indicating that larger molecules can
decrease the affinity of Avd(S16C) for biotin more efficiently.
The quenching of fluorescence of dcAvd-Cys coupled with
maleimide was 45.065.3% (Figure 3B), which was an intermediate
of the values measured for wt avidin and Avd(S16C). Therefore, it
seems that maleimide was able to inhibit the binding of biotin to the
cysteine-modified binding site in the cpAvd6R5 domain of the
dcAvd-Cys. Asa consequence, the remainingbiotin-bindingactivity
of dcAvd-Cys would depend mainly on the cpAvd5R4 domain,
which closely resembles that of wt avidin [17,20]. The rapid burst
(,10%) in the recovery of fluorescence just after the addition of free
biotin was most probably mainly associated with the dissociation of
fluorescent biotin from the cpAvd6R5 domain with the S16C
modified binding site.Theburstis followed bya slow phase ofbiotin
dissociation from the cpAvd5R4 domain with an unmodified
ligand-binding site. After an hour the recovery of fluorescence of
dcAvd-Cys-MI was 26.367.8% suggesting that the cpAvd5R4
domain had a wt-like biotin-binding affinity.
Again, the biotin dissociation results were confirmed using
3H-
biotin (Figure 3E,G). Maleimide had no effect on the ability of wt
avidin to bind or release
3H-biotin, since the amount of unbound
3H-biotin was 2.760.1% and the dissociation of the bound
3H-
biotin 24 hours after the addition of cold biotin was 7%. In
contrast, maleimide significantly reduced the ability of Avd(S16C)
to bind
3H-biotin as the amount of unbound
3H-biotin was
25.660.1%. Following the addition of a 1000-fold excess of cold
biotin, Avd(S16C) rapidly released over 85% of the bound
3H-
biotin and during 24 hours the release exceeded 90%. Further-
more, Mal-b-ala decreased the ability of Avd(S16C) to bind
3H-
biotin, since the amount of free
3H-biotin was 34.960.4% and
following the addition of cold biotin the dissociation of the bound
3H-biotin reached 100%. With dcAvd-Cys conjugated with
maleimide, the amount of unbound
3H-biotin was 16.560.3%
and the addition of cold biotin led to dissociation of 15% of the
bound biotin after 24 hours, showing a slight increase compared to
wt avidin.
According to both dissociation assays coupling with maleimide
increased the dissociation of BF560-biotin and
3H-biotin from
Avd(S16C), whereas the dissociation from dcAvd-Cys decreased in
comparison to non-conjugated proteins. We believe that mal-
eimide blocks most of the S16C-modified binding sites on dcAvd-
Cys and the unmodified sites behave like the binding sites of wt
avidin. We expect the coupling efficiency of dcAvd-Cys with
maleimide to be high, as was in the case of Avd(S16C).
Dual chain avidin with two different ligands
In order to demonstrate the possibility of introducing new
molecules to the cpAvd6R5 domain via a maleimide linker we
performed a fluorescence resonance energy transfer (FRET)
experiment. As a donor we used a fluorescent maleimide (MI)
derivative, DY560-MI, which reacts with the introduced thiol group
of Cys16 in the cpAvd6R5 domain forming a stable covalent
thioether bond. The fluorescent biotin derivative, DY633-biotin
acted as the acceptor occupying the unmodified biotin-binding site
in the cpAvd5R4 domain. See Figure S2 for structures of DY560-
MI and DY633-biotin. After exciting the complex with 560 nm, the
DY560-MI was found to transfer energy to the DY633-biotin
(Figure 4A). As a result, we saw quenching of the donor emission by
73% and increased acceptor emission (Figure 4C), suggesting the
coexistence of both dyes in the same protein tetramers. When the
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before addition of DY633-biotin, the emission of the donor was
quenched less than 13% (Figure 4D). The fluorescence spectra
normalized according to the maximum fluorescence at 590 nm of
dcAvd-Cys in the presence of both DY560-MI and DY633-biotin
clearly indicated an increase in acceptor emission when the donor
and the acceptor were bound to the same protein tetramer
(Figure 4E). The increase in acceptor emission was insignificant
when the unmodified binding sites were blocked with biotin before
the FRET experiment (Figure 4D,E). According to previous studies
the fluorescence of another biotin dye (DY630-biotin) increased
two-fold after the addition of avidin [19]. Similarly, DY633-biotin
also showed increased fluorescence emission accompanied by a
slight shift in the emission maximum to the longer wavelength when
bound to avidin or to dcAvd-Cys. Still, in the FRET experiments
the increase in fluorescence was only about 10% (data not
presented), since DY633 was excited at 559 nm, which is the
wavelength of the DY560 excitation maximum. This increase alone
did not explain the increase of the acceptor emission when both
donor and acceptor were present.
The size of the avidin tetramer is about 50650640 A ˚ and the
distance between neighboring cpAvd5R4 to cpAvd6R5 (subunit
oneandsubunittwo,orsubunitthree andsubunit four)biotintailsis
roughly 20 A ˚ (Figure 4B) as measured from the avidin 3D-structure
(PDB 2AVI) using the VMD 1.8.7 program. The fluorescent labels
used in the experiment have ten-atom (DY560-MI) and nine-atom
(DY633-biotin) flexible linkers. Therefore, the theoretical maximal
distance between labels attached to subunits one and two, or to
subunits three and four (for clarification, see also the three-
dimensional structure of avidin (Figure 1A), would be ,50 A ˚,
although the structural features of avidin limit the maximal distance
to around (30610) A ˚ in reality. In contrast, the distance between
biotin tails bound to another cpAvd5R4 - cpAvd6R5 pair over the
symmetry axis of a dcAvd molecule would be about 30 A ˚ and with
linkers (60610) A ˚. Taken together, if both DY560-MI and DY630-
biotin had been bound to subunits one and two, respectively, or to
subunits three and four, FRET should have been very efficient.
Therefore, our results suggest the binding of dyes to subunits one
and four, orto subunits twoand three. This assumptionis supported
by previous studies showing that the affinity towards biotinylated
dyes decreases when more than two dyes are bound per molecule
[23,24]. In other words, binding of DY560 equipped with a short
linker might inhibit the binding of DY633-biotin to the neighboring
binding site. This phenomenon known as anti-cooperative binding
is described elsewhere [24].
The efficiency of bioconjugation was determined as the degree
of labeling per tetramer (the measured absorbance data presented
as Table S2 in Supporting Information). Labeling of wt avidin
yielded no bound DY560-maleimides verifying the specificity of
the reaction. The degree of labeling was 0.660.1 per dcAvd-Cys
pseudotetramer. As a control, Avd(S16C) was also labeled with an
identical protocol and the degree of labeling was found to be 0.6
per tetramer. We would have expected a higher bioconjugation
efficiency, as results obtained by mass spectrometry suggested
nearly complete conjugation of Avd(S16C) both with maleimide
and N-ethylmaleimide. Thus the low conjugation efficiency may
be associated with the non-optimized structure of linker between
maleimide and the dye.
Discussion
A great number of studies performed during the past two
decades have indicated that the biotin-binding pocket of
(strept)avidin strongly favors its natural ligand, biotin, and it is
thus difficult to develop novel ligands, which are not competed out
by biotin [2]. Here we present a novel concept for engineering
these biotin-binding proteins. A single point mutation S16C in the
ligand-binding site of avidin generates an active thiol group, which
can be chemically linked to, for example maleimide, as shown
here. As a result, a targeted genetic engineering followed by a mild
chemical treatment can now be used to control the activity of
avidin. Introducing S16C mutation to dcAvd creates two modified
binding sites per pseudotetramer. Both mutant sites can be
controlled, while the two remaining binding sites resemble those of
wt avidin (Figure 3A). The possibility to further modify both biotin
binding sites in dcAvd independently provides new opportunities
for creating tailored avidins for applications in bio- and
nanotechnology. As demonstrated here, dcAvd-Cys can be used
in FRET experiments with maleimide- and biotin-dyes (Figure 4).
DcAvd-Cys might also prove to be a valuable building block for
creating molecular arrangements, for example on sensor surfaces.
The positioning of Cys16 in the ligand-binding pocket of
Avd(S16C) and dcAvd-Cys did not significantly affect protein
folding, since the proteins could be produced with standard
expression methods and the isolated proteins had normal
oligomeric states according to an SDS-PAGE assay. However,
replacing a serine residue in the biotin-binding pocket led to a
modest decrease in biotin-binding affinity, resembling that of the
previously introduced S16A mutation [7]. Importantly, the
location of the introduced cysteine residue was selected so that it
is not available for disulphide bonding between avidin subunits.
This improves the usability of the protein since reducing agents
and subsequent laborious buffer exchanges can be avoided.
The strategy used here could also be applied to the independent
modification of binding sites in single chain avidin (scAvd), which
has four binding sites in one polypeptide chain [18]. This would
make it possible to create avidins with one to four active binding
sites per tetramer, freely selecting the positioning of the active sites
(Figure 5). The advantage of the Cys-based strategy described here
is the wide availability of maleimide reagents, which enable
production of tailored proteins to different purposes. In addition, a
completely inactive binding site could be created, for example, by
combining the mutations S16R [25] and N118M [15]. Further-
more, we have recently modified avidin by random mutagenesis to
bind other small ligands. As a proof of principle, avidin was
modified to bind testosterone (Paldanius et al. unpublished results).
One may also envision an extension to the palette of chemicals
used in this scheme. As was demonstrated earlier, Tyr33 in avidin
can be specifically modified by tetranitromethane leading to
reversible biotin binding [26]. Since it is possible to apply the
mutation Y33F to avidin without severe loss in biotin-binding
affinity, one could use this to introduce other specific chemical
fingerprint to the subunits.
Finally, the properties of covalent and noncovalent binding are
different. In the case of avidin, biotin binding can be considered a
virtually irreversible reaction. However, if the bond is subjected to
mechanical force, the bond lifetime can decrease substantially
[27]. Therefore, the technology developed here offer great
potential for novel technologies, such as atomic force microscopy
(AFM) and molecular recognition force spectroscopy (MRFS),
relying on extremely stable and specific molecular bonding.
Materials and Methods
Design, production and purification of recombinant
proteins
The site-directed mutagenesis of the cDNA encoding avidin,
cpAvd6R5 and cpAvd5R4 was performed by the QuikChange
Avidin with Adjustable Ligand Binding Site
PLoS ONE | www.plosone.org 6 January 2011 | Volume 6 | Issue 1 | e16576Avidin with Adjustable Ligand Binding Site
PLoS ONE | www.plosone.org 7 January 2011 | Volume 6 | Issue 1 | e16576(Stratagene, La Jolla, CA, USA) or megaprimer methods [28].
Sequences of primers used in PCR are shown in Table S3. To
obtain efficient bacterial secretion the bacterial signal peptide
OmpA from Bordetella avium was used in front of the Avd(S16C)
sequence. The amplified PCR-product was extracted from an
agarose gel and subcloned into the pET101/D-TOPOH vector
according to the manufacturers instructions (Invitrogen, Carlsbad,
CA, USA). Similarly, mutagenized forms of cpAvd5R4(I117C)
and cpAvd6R5(S16C, V115H) were joined together by ligation
and the complete dcAvd-Cys was subcloned into a pFastBac
vector (Invitrogen). All constructs were confirmed by DNA
sequencing (ABI PRISM 3100 Genetic Analyzer, Applied
Biosystems).
Avidin and Avd(S16C) were produced in E. coli BL21-AI cells
(Invitrogen) as described in detail earlier [29]. The pET101/D-
based expression vectors were transformed into E. coli BL21-(AI)
cells (Invitrogen). The fresh transformants were cultured in
Lysogeny broth (LB) medium with supplements of 0.1% (w/v)
glucose and 100 mg/ml ampicillin at 27uC with rotation at
220 rev/min. When culture reached OD600 0.2–0.4 the protein
expression was induced by adding 0.2% (w/v) L-arabinose and
1 mM IPTG. Cultivation was continued at 27uC an additional
18 hours before cells were collected by centrifugation (5000 g,
10 min, 4uC).
The Bac-To-BacH baculovirus expression system (Invitrogen)
was used to produce dcAvd-Cys as instructed by the manufacturer
and as described in detail previously [22]. Briefly, the pFastBac
construct was transformed into E. coli DH10Bac cells to generate a
recombinant bacmid, which was purified and transfected into
Spodoptera frugiperda Sf9 insect cells to generate a recombinant
baculovirus. The primary baculovirus stock was further amplified
for a larger scale production of recombinant dcAvd-Cys.
Approximately 2610
8 Sf9 cells were seeded to a final volume of
100 ml of HyClone SFX-Insect cell culture medium (Thermo
Fisher Scientific, Waltham, MA, USA) without biotin in a 250 ml
Erlenmayer flask. Recombinant viruses were added in ratio of
1:100 and transfected cells were cultured for three days at 28uC
with rotation at 125 rev/min. The cells were pelleted by
centrifugation (500 g, 10 min, RT).
All produced proteins were purified in a single step with a 2-
iminobiotin affinity agarose column (Affiland S. A., Ans-Liege,
Belgium). First, cell pellets from E. coli cultivations containing
avidin and Avd(S16C) were suspended in 30 mM Tris-HCl buffer
(pH 8) containing 2 mM EDTA and 20% sucrose. Then lysozyme
was added to a final concentration of 2.5 mg/ml and cell lysates
were incubated on ice for 30 minutes. After this, 50 mM Tris-HCl
buffer (pH 8) containing 2 mM EDTA, 150 mM NaCl and 1%
Triton X-100 was added and cells were sonicated two times for
five min (50% duty cycle, 5 s on, 3 s off) on ice. This was followed
by centrifugation (15 000 g, 30 min, 4uC) of the cell lysate, after
which the supernatant was filtered and mixed with an equal
volume of binding buffer (50 mM Na-carbonate buffer (pH 11)
containing 1 M NaCl). The crude protein mixture was applied to
2-iminobiotin agarose (1 ml), which had previously been equili-
brated with binding buffer. The obtained mixture was incubated
for one hour on a rolling shaker at 4uC with subsequent
centrifugation (500 g, 5 min, RT) and two washing steps with
binding buffer. Finally, agarose was transferred to a column and
proteins were eluted in one ml fractions with 50 mM sodium
acetate buffer (pH 4) containing 100 mM NaCl.
The first steps of purification of dcAvd-Cys from insect cells
differed from the steps described above for purifications from
bacterial cells. First, the cell pellet from insect cell culture was
suspended in 50 mM Tris-HCl (pH 8) buffer containing 2 mM
EDTA, 150 mM NaCl and 1% Triton X-100. The obtained cell
lysate was sonicated two times for five min (50% duty cycle, 1 s on,
1 s off) on ice. The steps following sonication were similar to those
described above for avidin and Avd(S16C) purification.
Following purification all proteins were dialyzed against 50 mM
Na-phosphate buffer (pH 7.0) containing 100 mM NaCl. The
molecular masses of the proteins were analysed with 15% SDS-
PAGE gel stained with Coomassie Brilliant Blue. Proteins were
denaturated in SDS-PAGE sample buffer with or without a
reducing agent (b-mercaptoethanol) by heating at 95uC for ten
minutes. The protein concentrations were determined with a UV/
Vis spectrophotometer (NanoDrop 1000 Spectrophotometer,
Thermo Scientific, Wilmington, DE, USA) by measuring the
Figure 5. Strategies to selectively modify the binding sites of
single chain avidin. Since all four binding sites are encoded by one
polypeptide chain, each of them can be modified independently. A
combination of the mutations S16R [25] and N118M [15] would lead to
a completely inactive monomer, which could be useful in some
experiments. In our previous experiments we have generated a steroid
binding avidin as an example of an altered binding specificity
(Paldanius et al. unpublished results).
doi:10.1371/journal.pone.0016576.g005
Figure 4. A FRET experiment with dcAvd-Cys. (A) A schematic of the FRET of the dcAvd-Cys. The DY560-maleimide (DY560-MI) acting as a FRET
donor could be coupled to the Cys16-modified binding sites of dcAvd-Cys, whereas DY633-biotin acting as a FRET acceptor bound to the unmodified
binding sites. (B) A schematic of the distances of the fluorescent labels attached to dcAvd-Cys. The distance between labels attached to the same side
of the dcAvd-Cys molecule is limited by structural features of avidin to 30610 A ˚. In contrast, the distance between the labels bound to another
cpAvd5R4 - cpAvd6R5 pair over the symmetry axis of the avidin is ,60610 A ˚.( C, D) Fluorescence intensity of dcAvd-Cys with a FRET donor and
acceptor. The intensities are corrected for sample dilution. (C) After exciting the protein complex at 560 nm, the DY560-MI transfers energy to the
DY633-biotin, which caused quenching of the donor emission and increased acceptor emission. When the DY633-biotin incubated with dcAvd-Cys or
the DY633-biotin label alone was excited at 560 nm the complexes had a minimal fluorescence at 657 nm. (D) The quenching of the donor emission
decreased when the unmodified binding sites of DcAvd-Cys were blocked with biotin before the addition of DY633-biotin. (E) The fluorescence
spectra normalized according to the maximum fluorescence at 590 nm of dcAvd-Cys with donor and acceptor present clearly indicated acceptor
emission as a consequence of FRET. The acceptor emission was minimal when unmodified binding sites were blocked with biotin before the addition
of DY633-biotin indicating that FRET did not occur.
doi:10.1371/journal.pone.0016576.g004
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23615 M
21cm
21 for both avidin and Avd(S16C) monomers and
47355 M
21cm
21 for the dcAvd-Cys pseudodimer.
SDS-PAGE-based thermostability assay
Protein samples in the absence and in the presence of D-biotin
(Fluka Chemie GmbH, Buchs, Switzerland) were acetylated in
vitro. An equal volume of SDS-PAGE buffer with b-mercaptoeth-
anol was added and the samples were heated to selected
temperatures between RT and 100uC for 20 min. The oligomeric
states of the proteins were analysed by 15% SDS-PAGE gel
followed by Coomassie Brilliant Blue staining described in detail
by Bayer and his coworkers [30].
Maleimide treatment
Maleimide (Sigma-Aldrich, St. Louis, MO, USA) as well as N-
maleoyl-b-alanine (Mal-b-ala, Sigma-Aldrich) were dissolved in
DMSO and added in a 100-fold molar excess to the protein
solution in 50 mM Na-phosphate buffer (pH 7.0) containing
100 mM NaCl. The samples were incubated at RT for one hour.
Mass spectrometry
All mass spectrometric measurements were performed with a
4.7-T hybrid quadrupole–FT-ICR instrument (APEX-Qe
TM;
Bruker Daltonics, Billerica, MA, USA), described in detail earlier
[31]. Lyophilized avidins were dissolved in HPLC-grade water and
desalted with PD-10 columns (Amersham Biosciences, Uppsala,
Sweden), equilibrated in advance with 10 mM ammonium acetate
buffer (pH 6.8). Desalted protein samples were further concen-
trated with Microcon (3-kDa cut-off) centrifugal filter devices
(Millipore, Billerica, MA, USA). The samples (untreated or treated
with maleimide) were further diluted with acetonitrile/water/
acetic acid (49.5:49.5:1.0, v/v) solution and directly infused into
the ESI source at a flow rate of 1.5 mL/min. Maleimide and N-
ethylmaleimide (Sigma-Aldrich) were dissolved in HPLC-grade
DMSO to a concentration of ,3 mM, mixed with avidins (ten-
fold molar excess of maleimide) and subsequently incubated at RT
for 15–30 min before measurements. In-solution trypsin digestion
was performed by incubating 150 mlo fa1 0mM avidin sample
with 0.25 ml of 0.5 mg/ml trypsin (corresponding to ,1:40 w/w
trypsin:protein ratio) in 10 mM ammonium acetate buffer
(pH 6.8) for four hours at RT. The resulting peptide mixtures
were diluted two-fold with acetonitrile/acetic acid (99:1, vv) and
measured immediately. All mass values given in the text refer to
the most abundant isotopic masses, either experimentally
determined or theoretically calculated from the sequence-derived
atomic compositions, unless otherwise stated.
Biotin dissociation assays
The biotin-binding properties of avidins were studied by
dissociation assays using two different methods involving fluores-
cently labelled biotin (BF560-biotin
TM, ArcDia Ltd, Turku,
Finland) and radioactive biotin ([8,9-
3H]biotin, PerkinElmer,
Waltham, MA, USA). The measurements were performed at RT.
The fluorescence signal from unbound BF560-biotin
TM in 3 ml
(50 mM Na-phosphate buffer (pH 7.0) containing 650 mM NaCl)
was measured for 300 seconds. This was followed by the addition
of a two-fold molar excess of protein and the binding of the
fluorescent biotin was detected for 300 seconds as quenching of the
fluorescence. The fluorescence recovery was measured for one
hour after the addition of a 100-fold molar excess of free D-biotin
(Fluka Chemie GmbH). A QuantaMaster
TM spectrofluorometer
(Photon Technology International, Inc., Lawrenceville, NJ, USA)
was used to excite the sample at 560 nm and to detect emission at
576 nm. Each measurement was performed twice.
Radioactive
3H-biotin at a concentration of 10 nM was
incubated overnight with a 50 nM subunit concentration of
protein. The unbound
3H-biotin was separated from the protein-
ligand complex by centrifugal ultrafiltration through 30,000 MW
cutoff filters (Vivaspin 500 centrifugal concentrators, Sigma-
Aldrich). Measurements were performed in 50 mM Na-phosphate
buffer (pH 7.0) containing 100 mM NaCl and 10 mg BSA per ml
to prevent non-specific binding. To initiate the dissociation
reaction, cold biotin was added to a final concentration of
50 mM and the released
3H-biotin was separated from the protein-
ligand complex at different time points by ultrafiltration. The
radioactivity of the filtrate was analyzed in a Wallac 1410 liquid
scintillation counter (Wallac Oy, Turku, Finland). Triplicates of
each sample were measured at each time point.
The fraction of bound fluorescent or radioactive biotin at each
time point and the dissociation rate constants (kdiss) were





~ ln fraction bound ðÞ ð 1Þ
where xt is the total amount of fluorescent/radioactive ligand before
the addition of protein, x is the free biotin at each time point and x0
is the amount of free ligand in the presence of protein just before the
addition of the competing biotin [11]. The first 500 s were omitted
from the data to eliminate the effect of the fast initial-phase
characteristic of the avidin-BF650-biotin
TM interaction [7].
Fluorescence resonance energy transfer assay
The FRET donor DY560-maleimide (DY560-MI) (absorption/
emission max: 559 nm/578 nm (in ethanol), molar extinction
coefficient: 120.000 M
21cm
21) and the FRET acceptor DY633-
biotin (absorption/emission max.: 637 nm/657 nm (in ethanol),
molar extinction coefficient: 200.000 M
21cm
21) for this study
were supplied by Dyomics GmbH (Jena, Germany).
Proteins in 50 mM Na-phosphate buffer (pH 7.0) containing
100 mM NaCl were incubated with a five-fold molar excess of
DY560-MI for two hours at RT protected from light. The
obtained protein-dye conjugate was separated from the free dye by
dialysis. The absorption spectrum for the protein-dye conjugate
was recorded with a PerkinElmer Lambda 35 UV/Vis spectrom-
eter (PerkinElmer Life and Analytical Sciences) over the full
wavelength range. The absorption maxima of the wavelengths
280 nm and 560 nm were used to calculate a dye/protein ratio (5)
according to a formula derived from the Lambert-Beer law for the
absorption maximum of the dye (2) and for the absorption
maximum of the protein at 280 nm adjusted by a correction
factor, CF, (4) contributed by the dye absorbance at 280 nm. The
extinction coefficients used in the calculations were
94460 M
21cm
21 for the avidin and Avd(S16C) tetramers and
94710 M
21cm
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TM spectrofluorometer (Photon Technology
International, Inc., Lawrenceville, NJ, USA) was used to excite the
sample at 559 nm and to detect the emission spectra from 570 nm
to 700 nm. The measurements were performed at RT in a 50 mM
Na-phosphate buffer (pH 7.0) containing 100 mM NaCl. First, the
emission spectrum was measured for DY560-maleimide conjugat-
ed with dcAvd-Cys. This was followed by the addition of DY633-
biotin, after which the emission spectrum showing the quenching
of the donor emission and the increase of the acceptor emission
was measured. As a control measurement the emission spectrum
for DY633-biotin alone, and incubated with dcAvd-Cys without
DY560-MI were measured. Finally, free biotin was incubated with
dcAvd-Cys conjugated with DY560-maleimide and the emission
was measured before and after the addition of DY633-biotin. The
fluorescence intensities of the measured emission spectra were
corrected for sample dilution. Moreover, the fluorescence spectra
were normalized according to the maximum fluorescence of
dcAvd-Cys in the presence of both DY560-MI and DY633-biotin
at 590 nm to clearly indicate the occurrence of FRET when both
labels were bound to the same protein tetramer.
Supporting Information
Figure S1 SDS-PAGE thermal stability analysis of avidin,
Avd(S16C) and dcAvd-Cys without (2) and with (+) biotin. The
transition temperature was determined after 20 minute heat
treatment in the presence of SDS and b-mercaptoethanol followed
by SDS-PAGE analysis. M, molecular weight marker.
(TIF)
Figure S2 Structures of fluorescent conjugates used in FRET
experiment. (A) DY560-maleimide acting as a FRET donor and
(B) DY633-biotin acting as a FRET acceptor.
(TIF)
Table S1 Trypsin digestion data for Avidin, Avd(S16C) and
Avd(S16C) treated with maleimide. Three additional amino acid
residues (QTV) originating from the B. avium OmpA signal peptide
in the N-terminus of the protein are numbered to 23, 22 and 21.
Among the identified peptides for Avd(S16C) treated with
maleimide, a peptide having a monoisotopic mass of
1947.8630 Da was observed, consistent with the maleimide
conjugation into residues 10–26 (highlighted in red). With
untreated Avd(S16C), this peptide was absent, but a peptide
having a monoisotopic mass of 1850.8512 Da was observed
instead, corresponding to the uncoupled tryptic peptide 10–26
(highlighted in red).
(DOC)
Table S2 The degree of labeling per protein tetramer deter-
mined by measuring the absorbance at 280 nm and 560 nm for
avidin, Avd(S16C), dcAvd-Cys, and for the label, DY560-
maleimide (MI).
(DOC)
Table S3 Primers used in polymerase chain reactions (PCR).
(DOC)
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